The renin-angiotensin system and post-ischemic angiogenesis;Système rénine angiotensine et angiogenèse post-ischémique

Bulletin de l'Academie Nationale de Medecine

Volumn 188, Issue 4, 2004, Pages 649-659

  Silvestre, Jean Sébastien ^a   Lévy, Bernard I ^a   Ardaillou, M Raymond ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

Angiogenesis modulating agents; Angiotensin II; Anoxia; Bradykin; Inflammation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BRADYKININ; ENZYME INHIBITOR;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ANOXIA; BLOOD VESSEL; GENE THERAPY; INFLAMMATION; ISCHEMIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 7444258434     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33755-0     Document Type: Review

References (45)

1. DANSER A.H. - Local renin-angiotensin systems. Mol Cell Biochem. 1996 ; 157 : 211-216.
2. BERRY C., TOUYZ R., DOMINICZAK A.F., WEBB R.C., JOHNS D.G. - Angiotensin receptors : signaling, vascular pathophysiology, and interactions with ceramide. Am. J. Physiol. Heart. Circ. Physiol., 2001 ; 281 : H2337-H2365.
3. BERK B.C., CORSON M. A. - Angiotensin II signal transduction in vascular smooth muscle : role of tyrosine kinases. Circ. Res., 1997 ; 80 : 607-616.
4. NORA E.H., MUNZENMAIER D.H., HANSEN-SMITH F.M., LOMBARD J.H., GREENE A.S. - Localization of the ANGII type 2 receptor in the microcirculation of skeletal muscle. Am. J. Physiol., 1998 ; 275 : H1395-1403.
5. HORIUCHI M., AKISHITA M., DZAU V.J. - Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 1999 ; 33 : 613-621
6. TSUTSUMI Y., MATSUBARA H., MASAKI H., KURIHARA H., MURASAWA S., TAKAI S., MIYAZAKI M., NOZAWA Y., OZONO R., NAKAGAWA K., MIWA T., KAWADA N., MORI Y., SHIBASAKI Y., TANAKA Y., FUJIYAMA S., KOYAMA Y., FUJIYAMA A., TAKAHASHI H., IWASAKA T. -Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest., 1999 ; 104 : 925-935
7. RICHARD D.E., BERRA E., POUYSSEGUR J. - Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem., 2000 ; 275 : 26765-26771.
8. PAGE E.L., ROBITAILLE G.A., POUYSSEGUR J., RICHARD D.E. - Induction of Hypoxia-inducible Factor-1alpha by Transcriptional and Translational Mechanisms. J. Biol. Chem., 2002 ; 277 : 48403-48409.
9. TAMARAT R., SILVESTRE J.S., KUBIS N., BENESSIANO J., DURIEZ M., DE GASPARO M., HENRION D., LEVY B.I. - Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension. 2002 ; 39 : 830-835.
10. AMARAL S.L., LINDERMAN J.R., GREENE A.S. - Angiogenesis induced by electrical stimulation is mediated by angiotensin II. Microcirculation. 2000 ; 8 : 57-67.
11. AMARAL S.L., ROMAN R.J., GREENE A.S. - Renin gene transfer restores angiogenesis and vascular endothelial growth factor expression in Dahl S rats. Hypertension. 2001 ; 37 : 386-390.
12. KATADA J., MURAMATSU M., HAYASHI I., TSUTSUMI M., KONISHI Y., MAJIMA M. - Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J. Pharmacol. Exp. Ther. ? 2002 ; 302 : 949-956
13. FISCHER T.A., UNGUREANU-LONGROIS D., SINGH K., DE ZENGOTITA J., DEUGARTE D., ALALI A., BALLIGAND J.L., KIFOR I., SMITH T.W., KELLY. - Regulation of bFGF expression and ANGII secretion in cardiac myocytes and microvascular endothelial cells. Am. J. Physiol., 1999 ; 272 : 958-968.
14. FUJIYAMA S., MATSUBARA H., NOZAWA Y., MARUYAMA K., MORI Y., TSUTSUMI Y., MASAKI H., UCHIYAMA Y., KOYAMA Y., NOSE A., IBA O., TATEISHI E., OGATA N., JYO N., HIGASHIYAMA S., IWASAKA T. - Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ. Res., 2001 Jan 19 ; 88 : 22-29.
15. KATADA J., MURAMATSU M., HAYASHI I., TSUTSUMI M., KONISHI Y., MAJIMA M. -Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J. Pharmacol. Exp. Ther., 2002 ; 302 : 949-956.
16. SHINTANI S., MUROHARA T., IKEDA H., UENO T., HONMA T., KATOH A., SASAKI K.I., SHIMADA T., OIKE Y., IMAIZUMI T. - Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001 ; 103 : 2776-2779
17. LINSEMAN D.A., BENJAMIN C.W., JONES D.A. - Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J. Biol. Chem., 1995 ; 270 : 12563-12568.
18. DU J., SPERLING L.S., MARRERO M.B., PHILLIPS L., DELAFONTAINE P. - G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells : thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem. Biophys. Res. Commun., 1996 ; 218 : 934-939.
19. BRASIER A.R., RECINOS A. 3rd, ELEDRISI M.S. - Vascular inflammation and the renin-angiotensin system. Arterioscler. Thromb. Vasc. Biol., 2002 ; 22 : 1257-1266
20. ITO W.D., ARRAS M., WINKLER B., SCHOLZ D., SCHAFER J., SCHAFER W. - Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res., 1997 ; 80 : 829-837
21. IKEDA U., IKEDA M., OOHARA T., OGUCHI A., KAMITANI T., TSURUYA Y., KANO S. -Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am. J. Physiol, 1991 ; 260 : H1713-1717.
22. TUMMALA P.E., CHEN X.L., SUNDELL C.L., LAURSEN J.B., HAMMES C.P., ALEXANDER R.W., HARRISON D.G., MEDFORD R.M. - Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature : A potential link between the renin-angiotensin system and atherosclerosis. Circulation., 1999 ; 100 : 1223-1229.
23. HERNANDEZ-PRESA M., BUSTOS C., ORTEGO M., TUNON J., RENEDO G., RUIZ-ORTEGA M., EGIDO J. - Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation., 1997 ; 95 : 1532-1541.
24. HAN Y., RUGE M.S., BRASIER A.R. - Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ. Res., 1999 ; 84 : 695-703
25. TAMARAT R., SILVESTRE JS., DURIEZ M., LEVY B.I. - Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab. Invest., 2002 ; 82 : 747-756
26. LEVY B.I. - Can AT2 angiotensin receptors have deleterious effects in cardiovascular disease? Implication for therapeutic blockade of the renin-angiotensin system. Circulation., 2004 ; 109 : 8-13
27. STOLL M., STECKELINGS U.M., PAUL M., BOTTARI S.P., METZGER R. and UNGER T. -The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest., 1995 ; 95 : 651-7.
28. WALSH D.A., HU D.E., WHARTON J., CATRAVAS J.D., BLAKE D.R. and FAN T.P. -Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br. J. Pharmacol, 1997 ; 120 : 1302-11.
29. YAMADA T., AKISHITA M., POLLMAN M.J., GIBBONS G.H., DZAU V.J. and HORIUCHI M. - Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action : an in vitro gene transfer study. Life Sci., 1998 ; 63 : 289-295.
30. TEA B.S., SARKISSIAN S.D., TOUYZ R.M., HAMET P. and DEBLOIS D. - Proapoptotic and Growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension., 2000 ; 35 : 1069-1073.
31. HORIUCHI M., HAYASHIDA W., KAMBE T., YAMADA T., DZAU V.J. - Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem., 1997 ; 272 : 19022-19026.
32. SENBONMATSU T., ICHIHARA S., PRICE E., GAFFNEY A., INAGAMI T. - Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J. Clin. Invest., 2000 ; 106 : R25-R29
33. LEVY B., BENESIANO J., HENRION D., CAPUTO L., HEYMES C., DURIEZ M., POITEVIN P., SAMUEL J. L. - Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest., 1996 ; 98 : 418-425.
34. SILVESTRE J.S., TAMARAT R., SENBONMATSU T., ICCHIKI T., EBRAHIMIAN T., IGLARZ M., BESNARD S., DURIEZ M., INAGAMI T., LEVY B.I. - Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ. Res., 2002 ; 90 : 1072-1079.
35. NAKAJIMA M., HUTCHINSON H.G., FUJINAGA M., HAYASHIDA W., MORISHITA R., ZHANG L., HORIUCHI M., PRATT R.E., DZAU V.J. - The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor : gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. U S A., 1995 ; 92 : 10663-10667.
36. 2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension., 1997 ; 29 : 478-482
37. FABRE J.E., RIVARD A., MAGNER M., SILVER M., ISNER J.M. - Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation., 1999 ; 99 : 3043-3049
38. SILVESTRE J.S., KAMSU-KOM N., CLERGUE M., DURIEZ M., LEVY B.I. - Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs. J. Pharmacol. Exp. Ther., 2002 ;303 : 1038-1043
39. TAKESHITA S., TOMIYAMA H., YOKOYAMA N., KAWAMURA Y., FURUKAWA T., ISHIGAI Y., SHIBANO T., ISSHIKI T., SATO T. - Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res., 2001 ; 52 : 314-320.
40. MARGOLIUS H.S. - Kallikreins and Kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension., 1995 ; 26 : 221-229
41. 8desArg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats. Br. J. Pharmacol., 1993 ; 109 : 14-17
42. EMANUELI C., MINASI A., ZACHEO A., CHAO J., CHAO L., SALIS M.B., STRAINO S., TOZZI M.G., SMITH R., GASPA L., BIANCHINI G., STILLO F., CAPOGROSSI M.C., MADEDDU P. - Local delivery of human tissue kallikrein gene accelarates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation., 2001 ; 103 : 125-132
43. EMANUELI C., SALIS M.B., STACCA T., GASPA L., CHAO J., CHAO L., PIANA A., MADEDDU P. - Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene Hypertension., 2001 ; 38 : 136-141.
44. SILVESTRE J.S., BERGAYA S., TAMARAT R., DURIEZ M., BOULANGER C.M., LÉVY B.I. - Pro-angiogenic effect of angiotensin-converting enzyme is mediated by the Bradykinin B2 receptor pathway. Circ. Res., 2001 ; 89 : 678-683
45. 2 bradykinin receptor by ACE inhibitors. J. Biol. Chem., 2000 ; 275 : 16110-16118